Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
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
X0FeeBQuVAmNercY